Frontier Bio (FBIO) Bolstering it’s Warchest.
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering
Is True Nature (TNTY) $0.04, Nearing a Breakout?
After a Tough Year, a Series of Development Releases Appears to Have Halted True Natures Downtrend and Move to a Possible...
True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.
Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
AR Threats Report (CDC)
This report is dedicated to the 48,700 familieswho lose a loved one each year to antibiotic resistanceor Clostridioides difficile, and the...
Biotech’s Turning Up…
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News.
We keep telling investors...
True Nature | Mitesco (TNTY), Perking Up.
Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...
Dyadic (DYAI) Highlights.
"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and...
Mustang Bio (MBIO) Highlights.
"With a strong balance sheet and the continued advancement of our gene therapy and CAR T programs, we are well-positioned to execute...
Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...
We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...
True Nature (TNTY) Mitesco Set to Launch Mitesco PLC Incubator — Aligns With Matheson...
Hires Legal Powerhouse Matheson as Counsel and Advisor on its European Acquisitions Efforts.
Established...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
